Evidence map›Paper›PMID 30225924›Full record

ArticleClinical cardiology2018

Effects of socioeconomic status on clinical outcomes with ventricular assist devices.

Mustafa M Ahmed, Stephen M Magar, Eric I Jeng, George J Arnaoutakis, Thomas M Beaver, Juan Vilaro, Charles T Klodell, Juan M Aranda

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical cardiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Impact of Social Determinants of Health on Cardiovascular Disease.Journal of the American Heart Association · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mustafa M AhmedDivision of Cardiovascular Medicine, University of Florida, Gainesville, Florida.ORCID https://orcid.org/0000-0003-2781-7873
Stephen M MagarDepartment of Medicine, University of Florida, Gainesville, Florida.
Eric I JengDivision of Thoracic and Cardiovascular Surgery, University of Florida, Gainesville, Florida.
George J ArnaoutakisDivision of Thoracic and Cardiovascular Surgery, University of Florida, Gainesville, Florida.
Thomas M BeaverDivision of Thoracic and Cardiovascular Surgery, University of Florida, Gainesville, Florida.ORCID https://orcid.org/0000-0003-1785-0119
Juan VilaroDivision of Cardiovascular Medicine, University of Florida, Gainesville, Florida.
Charles T KlodellFlorida Heart and Lung Institute, Gainesville, Florida.
Juan M ArandaDivision of Cardiovascular Medicine, University of Florida, Gainesville, Florida.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLower socioeconomic status (SES) is a known risk factor for worse outcomes after major cardiovascular interventions. Furthermore, individuals with lower SES face barriers to evaluation for advanced heart failure therapies, including ventricular assist device (VAD) implantation. HYPOTHESIS: Examination of the effects of individual determinants of SES on VAD outcomes will show similar survival benefit in patients with lower compared with higher SES.

methodsAll VAD implants at the University of Florida from January 2008 to December 2015 were reviewed. Patient-level determinants of SES included place of residence, education level, marital status, insurance status, and financial resources stratified by percent federal poverty level. Survival or transplantation at 1 year, 30-day readmission, implant length of stay (LOS), and an aggregate of VAD-related complications were assessed in univariate fashion and multivariable regression modeling.

resultsA total of 111 patients were included (mean age at the time of implant 57.6 years, 82.8% men). More than half received destination therapy. At 1 year, 78.3% were alive on device support or had undergone successful transplantation. There were no differences in survival, 30-day readmission, or aggregate VAD complications by the SES category. Although patients with lower levels of education had longer LOS in univariate analysis, on multivariable ordinal regression modeling, this relationship was no longer seen.

conclusionsPatients with lower SES receive the same survival benefit from VAD implantation and are not more likely to have 30-day readmissions, complications of device support, or prolonged implant LOS. Therefore, VAD implantation should not be withheld based on these parameters alone.

Indexed as

Heart-Assist DevicesSocial ClassSocial Determinants of HealthVentricular Function, LeftAdultAgedAged, 80 and overEducational StatusFemaleFloridaHeart FailureHeart TransplantationHumansIncomeInsurance, HealthLength of Staysocioeconomic statusVAD

Identifiers

PMID30225924
PMCPMC6489719

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.